Takeda Pharmaceutical Financials

Takeda Pharmaceutical Stock Summary

Takeda Pharmaceutical competes with Cars, MINCO SILVER, Japan Medical, Diamyd Medical, and Commercial Vehicle. Takeda Pharmaceutical Company Limited, together with its subsidiaries, engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan. Takeda Pharmaceutical operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 49578 people.

Takeda Pharmaceutical Key Financial Ratios

There are many critical financial ratios that Takeda Pharmaceutical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Takeda Pharmaceutical reports annually and quarterly.

Takeda Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Takeda Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Takeda Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Takeda Pharmaceutical competition to find correlations between indicators driving Takeda Pharmaceutical's intrinsic value. More Info.Takeda Pharmaceutical is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about  0.52  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Takeda Pharmaceutical is roughly  1.93 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Takeda Pharmaceutical's earnings, one of the primary drivers of an investment's value.

Takeda Pharmaceutical Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Takeda Pharmaceutical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Takeda Pharmaceutical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Takeda Pharmaceutical based on widely used predictive technical indicators. In general, we focus on analyzing Takeda Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Takeda Pharmaceutical's daily price indicators and compare them against related drivers.

When running Takeda Pharmaceutical's price analysis, check to measure Takeda Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takeda Pharmaceutical is operating at the current time. Most of Takeda Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Takeda Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takeda Pharmaceutical's price. Additionally, you may evaluate how the addition of Takeda Pharmaceutical to your portfolios can decrease your overall portfolio volatility.